The UK’s self-regulated system for disclosing payments from drug companies to healthcare professionals and organizations is failing to protect patients and public trust, according to a new analysis led by researchers at the University of Bath, UK and Lund University, Sweden published in BMJ Evidence-Based Medicine.
Numinus Releases 2023 Financial Year Results— Finishing Strong | Psychedelic Invest
It is that time again when financial reports from the previous quarter start coming out. These documents let us know which companies are moving in
December 6, 2023